CADL NASDAQ
Candel Therapeutics, Inc.
1W: -11.0%
1M: +8.0%
3M: +55.2%
YTD: +45.8%
1Y: +34.2%
3Y: +401.9%
$7.99
+0.06 (+0.76%)
Weekly Expected Move ±12.9%
$7
$8
$9
$10
$11
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-54M
Net Income
-37.5% YoY
$-49M
Free Cash Flow
-80.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-92.0%
ROA-46.9%
ROIC67.6%
Valuation
P/E-9.2
P/B3.6
EV/EBITDA-3.7
Leverage
Debt/Equity0.04
Current Ratio13.31
Interest Cov.-15.1x
Quality Scores
Piotroski F3/9
Altman Z-0.36
Beneish M0.00